Thomas Thum

43.4k citations
410 papers · 24.5k indexed · 5 hit papers · h-index 86

Impact in

Papers in

Thomas Thum

397 papers receiving 24.2k citations

Hit Papers

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study 2020 · 266 citations
26620072026201320194008001.2k

Peers

Thomas Thum
Comparison fields: 5 of 159
  • Cancer Research 11.7k
  • Cardiology and Cardiovascular Medicine 5.6k
  • Molecular Biology 15.2k
  • Aging 169
  • Nephrology 626
Replace Holger K. Eltzschig with:
Holger K. Eltzschig United States
Robert E. Gerszten United States
Derek M. Yellon United Kingdom
Ryuichi Morishita Japan
Masatsugu Hori Japan
Douglas E. Vaughan United States
Rubin M. Tuder United States
Nikolaos G. Frangogiannis United States
Alain Tedgui France
Martin R. Bennett United Kingdom
Thomas Thum relative to Holger K. Eltzschig United States Holger K. Eltzschig's profile →
Citations per field
00.5×2.7×
Holger K. Eltzschig · 1×
Citations per year

Countries citing papers authored by Thomas Thum

Since Specialization
Citations

This map shows the geographic impact of Thomas Thum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Thum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Thum more than expected).

Fields of papers citing papers by Thomas Thum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Thum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Thum. The network helps show where Thomas Thum may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Thum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Thum Line = papers co-authored together Thomas Thum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20243
3 202410
4 20240
5 20242
6 202412
7 20245
8 20231
9 20233
10 202124
11 202019
12
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Hit paper breakdown →
2020266
13 202044
14 201927
15 201917
16 2017270
17 20177
18 201544
19 201410
20 201447

About Thomas Thum

Thomas Thum is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Molecular Biology, Physiology and Biochemistry, having authored 410 papers that have together received 24.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (150 papers), Circular RNAs in diseases (101 papers), Cancer-related molecular mechanisms research (88 papers), Cardiac Fibrosis and Remodeling (36 papers), Extracellular vesicles in disease (33 papers), RNA modifications and cancer (26 papers), RNA Interference and Gene Delivery (24 papers) and Nitric Oxide and Endothelin Effects (23 papers). The work is most often cited by research in Cancer Research (11.7k citations), Cardiology and Cardiovascular Medicine (5.6k citations), Molecular Biology (15.2k citations), Aging (169 citations) and Nephrology (626 citations). Thomas Thum has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Johann Bauersachs, Janika Viereck, Jürgen Borlak, Johan M. Lorenzen, Regalla Kumarswamy, Claudia Bang, Jan Fiedler, Christian Bär, Shashi Kumar Gupta and Ingo Volkmann. Their work appears in journals such as Cardiovascular Research, European Heart Journal, Journal of Molecular and Cellular Cardiology, European Journal of Heart Failure and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026